Dr Reddys Laboratories Stock Price Prediction

RDY Stock  USD 75.49  0.25  0.33%   
At this time, the relative strength index (rsi) of Dr Reddys' share price is at 57 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Dr Reddys' stock, making its price go up or down.

Oversold Vs Overbought

57

 
Oversold
 
Overbought
Dr Reddys Laboratories stock price prediction is an act of determining the future value of Dr Reddys shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Dr Reddys' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Dr Reddys and does not consider all of the tangible or intangible factors available from Dr Reddys' fundamental data. We analyze noise-free headlines and recent hype associated with Dr Reddys Laboratories, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Dr Reddys' stock price prediction:
Quarterly Earnings Growth
0.103
EPS Estimate Next Quarter
0.63
EPS Estimate Current Year
3.8
EPS Estimate Next Year
3.97
Wall Street Target Price
78.15
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Dr Reddys based on different types of headlines from major news networks to social media. The RDY stock price prediction module provides an analysis of price elasticity to changes in media outlook on Dr Reddys over a specific investment horizon. Using Dr Reddys hype-based prediction, you can estimate the value of Dr Reddys Laboratories from the perspective of Dr Reddys response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Dr Reddys using Dr Reddys' stock options and short interest. It helps to benchmark the overall future attitude of investors towards RDY using crowd psychology based on the activity and movement of Dr Reddys' stock price.

Dr Reddys Implied Volatility

    
  0.0  
Dr Reddys' implied volatility exposes the market's sentiment of Dr Reddys Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Dr Reddys' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Dr Reddys stock will not fluctuate a lot when Dr Reddys' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Dr Reddys. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Dr Reddys to buy its stock at a price that has no basis in reality. In that case, they are not buying RDY because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Dr Reddys after-hype prediction price

    
  USD 75.29  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current RDY contract

Based on the Rule 16, the options market is currently suggesting that Dr Reddys Laboratories will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-04-19 option contract. With Dr Reddys trading at USD 75.49, that is roughly USD 0.0 . If you think that the market is fully incorporating Dr Reddys' daily price movement you should consider acquiring Dr Reddys Laboratories options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out Dr Reddys Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Dr Reddys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Dr Reddys in the context of predictive analytics.
Intrinsic
Valuation
LowRealHigh
70.6271.8782.76
Details
Naive
Forecast
LowNextHigh
74.7275.9777.21
Details
5 Analysts
Consensus
LowTargetHigh
63.8070.1177.82
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.670.991.14
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Dr Reddys. Your research has to be compared to or analyzed against Dr Reddys' peers to derive any actionable benefits. When done correctly, Dr Reddys' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Dr Reddys Laboratories.

Dr Reddys After-Hype Price Prediction Density Analysis

As far as predicting the price of Dr Reddys at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dr Reddys or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Dr Reddys, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Dr Reddys Estimiated After-Hype Price Volatility

In the context of predicting Dr Reddys' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dr Reddys' historical news coverage. Dr Reddys' after-hype downside and upside margins for the prediction period are 74.04 and 76.54, respectively. We have considered Dr Reddys' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
75.49
75.29
After-hype Price
76.54
Upside
Dr Reddys is very steady at this time. Analysis and calculation of next after-hype price of Dr Reddys Laboratories is based on 3 months time horizon.

Dr Reddys Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Dr Reddys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dr Reddys backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dr Reddys, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.17 
1.24
  0.05 
  0.07 
12 Events / Month
7 Events / Month
In about 12 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
75.49
75.29
0.07 
427.59  
Notes

Dr Reddys Hype Timeline

On the 18th of March 2024 Dr Reddys Laboratories is traded for 75.49. The entity has historical hype elasticity of 0.05 and average elasticity to hype of competition of -0.07. RDY is forecasted to increase in value after the next headline with the price projected to jump to 75.29 or above. The average volatility of media hype impact on the company stock price is over 100%. The price jump on the next news is projected to be 0.07% whereas the daily expected return is at this time at 0.17%. The volatility of related hype on Dr Reddys is about 301.7% with expected price after next announcement by competition of 75.42. The company reported the last year's revenue of 245.88 B. Total Income to common stockholders was 60.48 B with profit before taxes, overhead, and interest of 113.84 B. Considering the 90-day investment horizon the next forecasted press release will be in about 12 days.
Check out Dr Reddys Basic Forecasting Models to cross-verify your projections.

Dr Reddys Related Hype Analysis

Having access to credible news sources related to Dr Reddys' direct competition is more important than ever and may enhance your ability to predict Dr Reddys' future price movements. Getting to know how Dr Reddys rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dr Reddys may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AAgilent Technologies(1.77)9 per month 1.39  0.05  2.73 (2.26) 9.31 
EQEquillium 0.24 8 per month 4.72  0.23  20.33 (9.64) 70.42 
KAKineta Inc(0.01)6 per month 0.00 (0.27) 8.54 (9.09) 72.56 
ME23Andme Holding Co(0.05)10 per month 0.00 (0.14) 10.47 (10.00) 34.64 
YSYS Biopharma Co(0.04)7 per month 5.61  0.09  13.16 (10.20) 37.30 
DMACDiaMedica Therapeutics(0.03)3 per month 3.23  0.01  6.02 (6.35) 20.43 
DMTKDermTech 0.07 6 per month 0.00 (0.17) 6.47 (8.24) 51.02 
VALNValneva SE ADR(0.14)6 per month 0.00 (0.18) 5.87 (4.94) 18.59 
VANIVivani Medical(2.31)10 per month 5.01  0.10  7.65 (7.96) 297.07 
VAXXVaxxinity(0.07)7 per month 5.12  0  8.82 (10.59) 45.91 

Dr Reddys Additional Predictive Modules

Most predictive techniques to examine RDY price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for RDY using various technical indicators. When you analyze RDY charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Dr Reddys Predictive Indicators

The successful prediction of Dr Reddys stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Dr Reddys Laboratories, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Dr Reddys based on analysis of Dr Reddys hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Dr Reddys's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Dr Reddys's related companies.
 2021 2022 2023 2024 (projected)
Price Earnings Ratio29.8817.2619.8418.85
Short Term Coverage Ratios1.04.835.554.3

Story Coverage note for Dr Reddys

The number of cover stories for Dr Reddys depends on current market conditions and Dr Reddys' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dr Reddys is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dr Reddys' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Dr Reddys Short Properties

Dr Reddys' future price predictability will typically decrease when Dr Reddys' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dr Reddys Laboratories often depends not only on the future outlook of the potential Dr Reddys' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dr Reddys' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding166.4 M
Cash And Short Term Investments66.7 B
When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out Dr Reddys Basic Forecasting Models to cross-verify your projections.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.103
Dividend Share
40
Earnings Share
3.78
Revenue Per Share
272.4618
Quarterly Revenue Growth
0.066
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.